Cargando…

MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression

BACKGROUND: So far, few have concerned miR-497-5p in lung squamous cell carcinoma (LUSC). METHODS: MiR-497-5p expression in LUSC was measured by qRT-PCR. Its impacts on tumor-related cell behaviors were investigated by CCK8 assay, scratch healing assay, flow cytometry and Transwell invasion methods....

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Jiangwei, Xiang, Xinqin, Guan, Wei, Lou, Weihua, He, Junming, Chen, Jian, Fu, Yin, Lou, Guoliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588708/ https://www.ncbi.nlm.nih.gov/pubmed/34772428 http://dx.doi.org/10.1186/s13019-021-01698-2

Ejemplares similares

miR-497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR-588/TUSC1 axis
por: Ji, Li-Ya, et al.
Publicado: (2021)

Downregulation of miR-497-5p Improves Sepsis-Induced Acute Lung Injury by Targeting IL2RB
por: Lou, Wei, et al.
Publicado: (2021)

Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma
por: Chen, Shuying, et al.
Publicado: (2021)

MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
por: Tian, Yao, et al.
Publicado: (2023)

Upregulation of miR-29c-3p Hinders Melanoma Progression by Inhibiting CDCA4 Expression
por: Liu, Jiazheng, et al.
Publicado: (2021)

miR-497 expression, function and clinical application in cancer
por: Yang, Gang, et al.
Publicado: (2016)

Target gene regulatory network of miR-497 in angiosarcoma
por: Benton, Annaleigh, et al.
Publicado: (2023)

Hypomethylation-Mediated AGR2 Overexpression Facilitates Cell Proliferation, Migration, and Invasion of Lung Adenocarcinoma
por: He, Junming, et al.
Publicado: (2021)

Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
por: Du, Mulong, et al.
Publicado: (2015)

FGFR1 is an independent prognostic factor and can be regulated by miR-497 in gastric cancer progression
por: Xie, Gang, et al.
Publicado: (2018)

The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis
por: Chen, Xiang, et al.
Publicado: (2017)

SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497
por: Ding, Qianshan, et al.
Publicado: (2016)

Aberrant Expression of miR-103, miR-184, miR-378, miR-497 and miR-506 in Tumor Tissue from Patients with Oral Squamous Cell Carcinoma Regulates the Clinical Picture of the Patients
por: Ghaffari, Maryam, et al.
Publicado: (2020)

Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV
por: Duan, Yantao, et al.
Publicado: (2014)

miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells
por: Hoareau-Aveilla, Coralie, et al.
Publicado: (2019)

The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression
por: Huang, Yong, et al.
Publicado: (2020)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

MicroRNA miR-497 is closely associated with poor prognosis in patients with cerebral ischemic stroke
por: Zhong, Changyang, et al.
Publicado: (2021)

LINC00511 promotes cervical cancer progression by regulating the miR-497-5p/MAPK1 axis
por: Lu, Mingming, et al.
Publicado: (2022)

Twist promotes angiogenesis in pancreatic cancer by targeting miR-497/VEGFA axis
por: Liu, An, et al.
Publicado: (2016)

Gastrodin promotes the regeneration of peripheral nerves by regulating miR-497/BDNF axis
por: Yongguang, Li, et al.
Publicado: (2022)

CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
por: Li, Hongyi, et al.
Publicado: (2021)

Hsa_circ_0008259 modulates miR-21-5p and PDCD4 expression to restrain osteosarcoma progression
por: Guan, Kai, et al.
Publicado: (2021)

MiR-490-5p Restrains Progression of Gastric cancer through DTL Repression
por: Li, Jianjie, et al.
Publicado: (2021)

Linc00662 Promotes Tumorigenesis and Progression by Regulating miR-497-5p/AVL9 Axis in Colorectal Cancer
por: Wang, Huaiming, et al.
Publicado: (2020)

Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer
por: Zhang, Yujuan, et al.
Publicado: (2015)

CDCA8 Contributes to the Development and Progression of Thyroid Cancer through Regulating CDK1
por: Xiang, Cheng, et al.
Publicado: (2022)

MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis
por: Xu, Jianwei, et al.
Publicado: (2014)

MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1
por: Yan, Jing-Jun, et al.
Publicado: (2015)

miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer
por: Fridrichova, Ivana, et al.
Publicado: (2020)

miR-195/miR-497 Regulate CD274 Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer
por: Yang, Lianzhou, et al.
Publicado: (2018)

Differential roles of miR‐15a/16‐1 and miR‐497/195 clusters in immune cell development and homeostasis
por: Hutter, Katharina, et al.
Publicado: (2020)

miR-145 and miR-497 suppress TGF-β-induced epithelial–mesenchymal transition of non-small cell lung cancer by targeting MTDH
por: Yin, Qi, et al.
Publicado: (2018)

Circ_0001421 facilitates glycolysis and lung cancer development by regulating miR-4677-3p/CDCA3
por: Zhang, Koudong, et al.
Publicado: (2020)

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells
por: Xu, Bing, et al.
Publicado: (2021)

MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer
por: Bai, Dongfang, et al.
Publicado: (2017)

miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1)
por: Han, Zhiyuan, et al.
Publicado: (2015)

The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival
por: Ali, Dina A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h5768g2hjugdr8gjucusvbdi66